147 related articles for article (PubMed ID: 19449003)
1. Effective treatment of pancreatic neuroendocrine tumours transfected with the sodium iodide symporter gene by 186Re-perrhenate in mice.
Riese CG; Seitz S; Schipper ML; Behr TM
Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1767-73. PubMed ID: 19449003
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo.
Zuckier LS; Dohan O; Li Y; Chang CJ; Carrasco N; Dadachova E
J Nucl Med; 2004 Mar; 45(3):500-7. PubMed ID: 15001694
[TBL] [Abstract][Full Text] [Related]
3. Treatment with rhenium-188-perrhenate and iodine-131 of NIS-expressing mammary cancer in a mouse model remarkably inhibited tumor growth.
Dadachova E; Nguyen A; Lin EY; Gnatovskiy L; Lu P; Pollard JW
Nucl Med Biol; 2005 Oct; 32(7):695-700. PubMed ID: 16243644
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
5. Rhenium-188 as an alternative to Iodine-131 for treatment of breast tumors expressing the sodium/iodide symporter (NIS).
Dadachova E; Bouzahzah B; Zuckier LS; Pestell RG
Nucl Med Biol; 2002 Jan; 29(1):13-8. PubMed ID: 11786271
[TBL] [Abstract][Full Text] [Related]
6. Anion selectivity by the sodium iodide symporter.
Van Sande J; Massart C; Beauwens R; Schoutens A; Costagliola S; Dumont JE; Wolff J
Endocrinology; 2003 Jan; 144(1):247-52. PubMed ID: 12488351
[TBL] [Abstract][Full Text] [Related]
7. Use of rhenium-188 for in vivo imaging and treatment of human cervical cancer cells transfected with lentivirus expressing sodium iodide symporter.
Zhang M; Shi S; Guo R; Miao Y; Li B
Oncol Rep; 2016 Oct; 36(4):2289-97. PubMed ID: 27573304
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo.
Schipper ML; Riese CGU; Seitz S; Weber A; Béhé M; Schurrat T; Schramm N; Keil B; Alfke H; Behr TM
Eur J Nucl Med Mol Imaging; 2007 May; 34(5):638-650. PubMed ID: 17160413
[TBL] [Abstract][Full Text] [Related]
9. Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression.
Willhauck MJ; Sharif Samani BR; Gildehaus FJ; Wolf I; Senekowitsch-Schmidtke R; Stark HJ; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2007 Nov; 92(11):4451-8. PubMed ID: 17698909
[TBL] [Abstract][Full Text] [Related]
10. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
11. In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter.
Shi S; Zhang M; Guo R; Miao Y; Hu J; Xi Y; Li B
PLoS One; 2015; 10(1):e0116531. PubMed ID: 25621996
[TBL] [Abstract][Full Text] [Related]
12. Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells.
Schipper ML; Weber A; Béhé M; Göke R; Joba W; Schmidt H; Bert T; Simon B; Arnold R; Heufelder AE; Behr TM
Cancer Res; 2003 Mar; 63(6):1333-8. PubMed ID: 12649195
[TBL] [Abstract][Full Text] [Related]
13. Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer.
Penheiter AR; Wegman TR; Classic KL; Dingli D; Bender CE; Russell SJ; Carlson SK
AJR Am J Roentgenol; 2010 Aug; 195(2):341-9. PubMed ID: 20651188
[TBL] [Abstract][Full Text] [Related]
14. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.
Schmohl KA; Gupta A; Grünwald GK; Trajkovic-Arsic M; Klutz K; Braren R; Schwaiger M; Nelson PJ; Ogris M; Wagner E; Siveke JT; Spitzweg C
Oncotarget; 2017 May; 8(20):33393-33404. PubMed ID: 28380420
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene.
Lee YJ; Chung JK; Shin JH; Kang JH; Jeong JM; Lee DS; Lee MC
Thyroid; 2004 Nov; 14(11):889-95. PubMed ID: 15671766
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors.
Dwyer RM; Bergert ER; O'Connor MK; Gendler SJ; Morris JC
Hum Gene Ther; 2006 Jun; 17(6):661-8. PubMed ID: 16776574
[TBL] [Abstract][Full Text] [Related]
17. Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene delivery.
Klutz K; Willhauck MJ; Wunderlich N; Zach C; Anton M; Senekowitsch-Schmidtke R; Göke B; Spitzweg C
Hum Gene Ther; 2011 Nov; 22(11):1403-12. PubMed ID: 21488714
[TBL] [Abstract][Full Text] [Related]
18. Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene.
Carlson SK; Classic KL; Hadac EM; Dingli D; Bender CE; Kemp BJ; Russell SJ
AJR Am J Roentgenol; 2009 Jan; 192(1):279-87. PubMed ID: 19098211
[TBL] [Abstract][Full Text] [Related]
19. In vivo radioiodide imaging and treatment of pancreatic cancer xenografts after MUC1 promoter-driven expression of the human sodium-iodide symporter.
Chen RF; Li ZH; Pan QH; Zhou JJ; Tang QB; Yu FY; Zhou QB; Wang J; Chen JS
Pancreatology; 2007; 7(5-6):505-13. PubMed ID: 17912014
[TBL] [Abstract][Full Text] [Related]
20. Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells.
Chai W; Yin X; Ren L; Cai M; Long T; Zhou M; Tang Y; Yang N; Hu S
Clin Transl Oncol; 2015 Oct; 17(10):795-802. PubMed ID: 26115738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
